Medicaid Adult Core Set: Evaluation of Hepatitis B and C measure added for 2027

“The following measures are being added to the 2027 Adult Core Set for voluntary state reporting” (opens the source at this quote in a new tab)
“This measure assesses the number and percentage of adult, non-dually eligible Medicaid beneficiaries who were tested for hepatitis B, tested for hepatitis C, and treated for hepatitis C. Timely testing, diagnosis, and treatment of hepatitis can prevent serious liver damage and improve outcomes.” (opens the source at this quote in a new tab)
“Measure Steward: Medicaid Outcomes Distributed Research Network’s (MODRN) Data Coordinating Center at the University of Pittsburgh” (opens the source at this quote in a new tab)

Evaluation of Hepatitis B and C measure: listing in the 2027 Adult Core Set

Field	2027 Adult Core Set
Reporting category	“2027 Voluntary Adult Core Set Measures”
Domain	“Primary Care Access and Preventive Care”
CMIT number	“1852”
Measure steward	“MODRN”
Measure name	“Evaluation of Hepatitis B and C (EHBC-AD)”
Data collection method	“Administrative”
Status	“This measure was added to the 2027 Adult Core Set.”

Evaluation of Hepatitis B and C measure: reported rates, populations, and testing results

“Nine rates are reported for this measure across three populations: all adults, adults diagnosed with opioid use disorder (OUD), and pregnant women.” (opens the source at this quote in a new tab)
“The individual who suggested this measure said it is not currently in use by any state Medicaid or CHIP programs but was tested in seven state Medicaid programs” (opens the source at this quote in a new tab)
“They noted that measure testing results showed that hepatitis screening and treatment rates are low” (opens the source at this quote in a new tab)
“a Workgroup member said this is a testing measure rather than a screening measure and is not intended to capture everyone. They added that hepatitis B testing rates were low across states where the measure was tested, highlighting an opportunity to develop targeted testing strategies.” (opens the source at this quote in a new tab)

Viral hepatitis quality measures with a hepatitis B component in federal and commercial programs

Measure	Brief description	Identifier	Steward	Programs using the measure
Evaluation of Hepatitis B and C (EHBC-AD)	“Assess the number and percentage of adult, non-dually eligible Medicaid beneficiaries who were tested for hepatitis B, tested for hepatitis C, and treated for hepatitis C.”	“CMIT: 1852”	“MODRN”	“Medicaid Adult Core Set (2027)”
Adult Immunization Status	“Percentage of patients 19 years of age and older who are up-to-date on recommended routine vaccines for influenza; tetanus and diphtheria (Td) or tetanus, diphtheria and acellular pertussis (Tdap); zoster; pneumococcal; and hepatitis B.”	“MIPS: 493”“CMIT: 26”	“NCQA”	“MIPS Program”“Medicaid Adult Core Set”“HEDIS”“QHP QRS”

Healthy People 2030 objective IID-13: awareness of chronic hepatitis B infection

Field	Objective record
Objective	“Increase the proportion of persons aware they have chronic hepatitis B”
National baseline	“32.4 percent of persons with chronic hepatitis B were aware they have chronic hepatitis B in 2013-16”
National target	“90.0 percent”
National status	“Baseline only”
Data source	“National Health and Nutrition Examination Survey (NHANES), CDC/NCHS”

Healthy People 2030 objective IID-15: deaths with hepatitis B as a cause

Field	Objective record
Objective	“Reduce the rate of deaths with hepatitis B as the underlying or a contributing cause”
National baseline	“0.46 deaths with hepatitis B as the underlying or contributing cause of death per 100,000 population were reported in 2017”
Most recent data	“0.40 deaths with hepatitis B as the underlying or contributing cause of death per 100,000 population (2024)”
National target	“0.16 per 100,000”
National status	“Improving”

Viral Hepatitis National Strategic Plan: hepatitis B core indicators and targets

Core indicator	Measure	Baseline	2025 target	2030 target
“Reduce acute hepatitis B infections”	“Estimated number of cases”	“22,200”	“18,000”	“2,200”
“Increase proportion of people with hepatitis B infection aware of their infection”	“Rate/100,000”	“32 (2013–2016 baseline)”	“50”	“90”
“Reduce rate of hepatitis B–related deaths”	“Rate/100,000”	“0.46”	“0.37”	“0.16”

CDC universal hepatitis B screening recommendation and national awareness goal

“HBV screening at least once during a lifetime for adults aged ≥18 years (new recommendation)” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“calls for an increase in the proportion of persons with HBV infection who are aware of their infection from 32% (2013–2016) to 90% by 2030” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote

Product-specific effect on quality measures

No evidence found.